The present invention provides a compound of formula (1), or pharmaceutical acceptable salts thereof wherein R1 is C4-12 alkyl, C4-12 alkenyl, C4-12 alkynyl, —(CH2)h-C3-8 cycloalkyl, substituted and unsubstituted —(CH2)h-aryl, substituted and unsubstituted-(CH2)h-het, R2 is substituted and unsubstituted C1-12 alkyl, substituted and unsubstituted C2-12 alkenyl, substituted and unsubstituted C2-12 alkynyl, substituted and unsubstituted-(CH2)h-C3-8 cycloakyl, substituted and unsubstituted —(CH2)h-C3-8 unsubstituted-(CH2)h-C3-8 cycloakyl, substituted and unsubstituted —(CH2)h-C3-8 cycloalkenyl, substituted and unsubstituted-(CH2)h-aryl, substituted and unsubstituted-(CH2)h-heterocyclic ring, substituted and unsubstituted —(CH2)i-X—R4 (X is —O—, —S(═O)j-, —NR7-, —S(═O)2NR8-, or —C(═O)—), and —(CH2)iCHR5R6. The compounds are inhibitors of matrix metalloproteinases involved in tissue degradation
本发明提供了一种化合物,其
化学式为(1),或其药物可接受的盐,其中R1为C4-12烷基,C4-12烯基,C4-12炔基,-(
CH2)h-C3-8环烷基,取代和未取代的-( )h-芳基,取代和未取代的-( )h-杂环基,R2为取代和未取代的C1-12烷基,取代和未取代的C2-12烯基,取代和未取代的C2-12炔基,取代和未取代的-( )h-C3-8环烷基,取代和未取代的-( )h-C3-8未取代的-( )h-C3-8环烷基,取代和未取代的-( )h-C3-8环烯基,取代和未取代的-( )h-芳基,取代和未取代的-( )h-杂环环,取代和未取代的-( )i-X-R4(X为—O—,—S(═O)j-,—NR7-,—S(═O)2NR8-,或—C(═O)—),以及-( )iCHR5R6。这些化合物是参与组织降解的基质
金属
蛋白酶的
抑制剂。